Company Name: XTL Biopharmaceuticals Ltd.    

XTL Biopharmaceuticals Ltd. is a biopharmaceutical company. The company is focused on the development of treatments for autoimmune diseases. The company’s lead product candidate is a treatment for systemic lupus erythematosus (SLE).

Ticker Symbol: XTLB (NASDAQ)

Company Website: www.xtlbio.com

Social Media: XTL Biopharmaceuticals LinkedIn

Headquarters: Raanana, Israel